tradingkey.logo

Xtant Medical Holdings Inc

XTNT
0.591USD
+0.030+5.23%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
82.78MValor de mercado
45.70P/L TTM

Xtant Medical Holdings Inc

0.591
+0.030+5.23%

Mais detalhes de Xtant Medical Holdings Inc Empresa

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Informações de Xtant Medical Holdings Inc

Código da empresaXTNT
Nome da EmpresaXtant Medical Holdings Inc
Data de listagemJun 30, 2010
CEOBrowne (Sean E)
Número de funcionários217
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 30
Endereço664 Cruiser Lane
CidadeBELGRADE
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal59714
Telefone14063880480
Sitehttps://xtantmedical.com/
Código da empresaXTNT
Data de listagemJun 30, 2010
CEOBrowne (Sean E)

Executivos da empresa Xtant Medical Holdings Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.52M
+553797.00%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
914.12K
+158228.00%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
566.93K
-8084.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
+158228.00%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.52M
+553797.00%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
914.12K
+158228.00%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
566.93K
-8084.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
+158228.00%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Orthobiologics
17.15M
51.57%
Spinal implant
10.62M
31.94%
License revenue
5.48M
16.49%
Por RegiãoUSD
Nome
Receita
Proporção
United States
30.31M
91.15%
Rest of World
2.94M
8.85%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Orthobiologics
17.15M
51.57%
Spinal implant
10.62M
31.94%
License revenue
5.48M
16.49%

Distribuição de ações

Atualizado em: sáb, 22 de nov
Atualizado em: sáb, 22 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Nantahala Capital Management, LLC
48.85%
Lytton (Laurence W)
6.76%
Vizirgianakis (Stavros G)
5.37%
AWM Investment Company, Inc.
4.71%
The Vanguard Group, Inc.
1.62%
Outro
32.69%
Investidores
Investidores
Proporção
Nantahala Capital Management, LLC
48.85%
Lytton (Laurence W)
6.76%
Vizirgianakis (Stavros G)
5.37%
AWM Investment Company, Inc.
4.71%
The Vanguard Group, Inc.
1.62%
Outro
32.69%
Tipos de investidores
Investidores
Proporção
Hedge Fund
49.59%
Individual Investor
16.45%
Investment Advisor/Hedge Fund
5.20%
Investment Advisor
2.29%
Research Firm
0.04%
Outro
26.42%

Participação acionária institucional

Atualizado em: qua, 21 de jan
Atualizado em: qua, 21 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q4
41
80.10M
114.61%
--
2025Q4
60
79.99M
57.14%
-82.24M
2025Q3
58
80.07M
57.19%
-75.11M
2025Q2
66
93.42M
67.06%
-16.04M
2025Q1
66
107.33M
77.15%
-2.25M
2024Q4
65
107.45M
77.30%
-1.32M
2024Q3
60
109.08M
78.63%
+8.43M
2024Q2
61
99.68M
76.50%
-1.69M
2024Q1
63
100.56M
77.45%
+777.79K
2023Q4
59
100.17M
77.23%
+1.05M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Nantahala Capital Management, LLC
68.39M
48.85%
--
--
Sep 30, 2025
Lytton (Laurence W)
9.46M
6.76%
+9.46M
--
Apr 15, 2025
Vizirgianakis (Stavros G)
7.52M
5.37%
+553.80K
+7.95%
Nov 15, 2025
AWM Investment Company, Inc.
6.59M
4.71%
-2.50K
-0.04%
Sep 30, 2025
The Vanguard Group, Inc.
2.36M
1.68%
+104.16K
+4.63%
Sep 30, 2025
Browne (Sean E.)
1.94M
1.39%
+394.94K
+25.57%
Nov 15, 2025
Beeson (Jonn R.)
1.53M
1.09%
+158.23K
+11.51%
Nov 15, 2025
Bakewell (John K)
1.07M
0.77%
+316.46K
+41.87%
Nov 15, 2025
Renaissance Technologies LLC
713.91K
0.51%
+63.20K
+9.71%
Sep 30, 2025
Neils (Scott C)
575.01K
0.41%
+263.29K
+84.46%
Nov 15, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI